Table 1.
Model 1 | Model 2 | Model 3 | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
β | CI | p | β | CI | p | β | CI | p | ||
C-peptidea | Total fatty acids | −14.9 | −201.4–171.7 | 0.875 | −7.5 | −202.1–187.1 | 0.939 | −43.3 | −243.0–156.5 | 0.669 |
SFA | 0.6 | −66.0–67.3 | 0.985 | 6.5 | −62.9–75.9 | 0.853 | −0.7 | −72.3–70.8 | 0.984 | |
MUFA | 19.0 | −38.3–76.3 | 0.512 | 21.2 | −38.5–81.0 | 0.483 | 8.5 | −52.7–69.8 | 0.783 | |
PUFA n-3 | −17.0 | −31.2–−2.8 | 0.019 | −17.1 | −32.0–−2.3 | 0.024 | −21.5 | −36.5–−6.4 | 0.006 | |
PUFA n-6 | −17.5 | −93.25–−58.3 | 0.648 | −18.1 | −97.1–61.0 | 0.652 | −29.7 | −110.8–−51.4 | 0.470 | |
Ratio n-6/n-3 | 0.69 | 0.12–1.25 | 0.018 | 0.69 | 0.10–1.28 | 0.022 | 0.78 | 0.17–1.38 | 0.012 | |
ISHOMAa | Total fatty acids | 35.0 | −131.2–201.3 | 0.677 | 30.9 | −142.1–203.8 | 0.677 | 69.6 | −111.4–250.5 | 0.448 |
SFA | 10.5 | −48.9–69.9 | 0.727 | 6.5 | −55.2–68.1 | 0.836 | 14.4 | −50.4–79.2 | 0.661 | |
MUFA | −8.5 | −59.7–42.6 | 0.742 | −9.1 | −62.3–44.1 | 0.735 | 3.3 | −52.3– 58.8 | 0.908 | |
PUFA n-3 | 15.1 | 2.5–27.8 | 0.020 | 15.2 | 2.0–28.3 | 0.025 | 20.1 | 6.4–33.7 | 0.004 | |
PUFA n-6 | 18.0 | −49.6–85.5 | 0.599 | 18.4 | −51.9–88.6 | 0.605 | 31.8 | −41.6–105.3 | 0.392 | |
Ratio n-6/n-3 | −0.59 | −1.09–−0.09 | 0.022 | −0–0.59 | −1.12–−0.07 | 0.027 | −0.69 | −1.24–−1.14 | 0.014 |
Model 1: adjusted for gestational age, maternal age, and processing time. Model 2: Model 1 + BMI adjustment. Model 3: Model 1 + leptin adjustment. Bold: Statistically significant difference after correction for multiple testing (FDR = 0.2). β: β estimate; CI: 95% confidence interval. SFA: sum of 14:0, 16:0, and 18:0; MUFA: sum of 16:1, 18:1, and 22:1; n-3 PUFA: sum of 18:3, 20:3, 20:5, 22:5, and 22:6; n-6 PUFA: sum of 18:2, 18:3, 20:3, 20:4, 22:2, 22:4, and 22:5. An ln-transformed variable. Non-normally distributed variables were ln-transformed to meet the requirements of multivariate linear regression analysis. Each 1% increase in the predictor variable (C-peptide and ISHOMA) increases the outcome variable by 1/100 units of the estimate. For example, a 1% increase in C-peptide is associated with a 0.17 mg/L decrease in n-3 PUFA.